Cargando…
P829: A PHASE III RANDOMIZED CLINICAL TRIAL COMPARING SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) WITH REFERENCE ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429509/ http://dx.doi.org/10.1097/01.HS9.0000846200.39589.36 |
| _version_ | 1784779465424896000 |
|---|---|
| author | Jang, J. H. Demichelis Gomez, R. Bumbea, H. Nogaieva, L. Wong, L. L. L. Lim, S. M. Park, J. Kim, Y. Cho, S. |
| author_facet | Jang, J. H. Demichelis Gomez, R. Bumbea, H. Nogaieva, L. Wong, L. L. L. Lim, S. M. Park, J. Kim, Y. Cho, S. |
| author_sort | Jang, J. H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429509 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94295092022-08-31 P829: A PHASE III RANDOMIZED CLINICAL TRIAL COMPARING SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) WITH REFERENCE ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA Jang, J. H. Demichelis Gomez, R. Bumbea, H. Nogaieva, L. Wong, L. L. L. Lim, S. M. Park, J. Kim, Y. Cho, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429509/ http://dx.doi.org/10.1097/01.HS9.0000846200.39589.36 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Jang, J. H. Demichelis Gomez, R. Bumbea, H. Nogaieva, L. Wong, L. L. L. Lim, S. M. Park, J. Kim, Y. Cho, S. P829: A PHASE III RANDOMIZED CLINICAL TRIAL COMPARING SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) WITH REFERENCE ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
| title | P829: A PHASE III RANDOMIZED CLINICAL TRIAL COMPARING SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) WITH REFERENCE ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
| title_full | P829: A PHASE III RANDOMIZED CLINICAL TRIAL COMPARING SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) WITH REFERENCE ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
| title_fullStr | P829: A PHASE III RANDOMIZED CLINICAL TRIAL COMPARING SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) WITH REFERENCE ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
| title_full_unstemmed | P829: A PHASE III RANDOMIZED CLINICAL TRIAL COMPARING SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) WITH REFERENCE ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
| title_short | P829: A PHASE III RANDOMIZED CLINICAL TRIAL COMPARING SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) WITH REFERENCE ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
| title_sort | p829: a phase iii randomized clinical trial comparing sb12 (proposed eculizumab biosimilar) with reference eculizumab in patients with paroxysmal nocturnal hemoglobinuria |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429509/ http://dx.doi.org/10.1097/01.HS9.0000846200.39589.36 |
| work_keys_str_mv | AT jangjh p829aphaseiiirandomizedclinicaltrialcomparingsb12proposedeculizumabbiosimilarwithreferenceeculizumabinpatientswithparoxysmalnocturnalhemoglobinuria AT demichelisgomezr p829aphaseiiirandomizedclinicaltrialcomparingsb12proposedeculizumabbiosimilarwithreferenceeculizumabinpatientswithparoxysmalnocturnalhemoglobinuria AT bumbeah p829aphaseiiirandomizedclinicaltrialcomparingsb12proposedeculizumabbiosimilarwithreferenceeculizumabinpatientswithparoxysmalnocturnalhemoglobinuria AT nogaieval p829aphaseiiirandomizedclinicaltrialcomparingsb12proposedeculizumabbiosimilarwithreferenceeculizumabinpatientswithparoxysmalnocturnalhemoglobinuria AT wonglll p829aphaseiiirandomizedclinicaltrialcomparingsb12proposedeculizumabbiosimilarwithreferenceeculizumabinpatientswithparoxysmalnocturnalhemoglobinuria AT limsm p829aphaseiiirandomizedclinicaltrialcomparingsb12proposedeculizumabbiosimilarwithreferenceeculizumabinpatientswithparoxysmalnocturnalhemoglobinuria AT parkj p829aphaseiiirandomizedclinicaltrialcomparingsb12proposedeculizumabbiosimilarwithreferenceeculizumabinpatientswithparoxysmalnocturnalhemoglobinuria AT kimy p829aphaseiiirandomizedclinicaltrialcomparingsb12proposedeculizumabbiosimilarwithreferenceeculizumabinpatientswithparoxysmalnocturnalhemoglobinuria AT chos p829aphaseiiirandomizedclinicaltrialcomparingsb12proposedeculizumabbiosimilarwithreferenceeculizumabinpatientswithparoxysmalnocturnalhemoglobinuria |